BRPA Big Rock Partners Acquisition Corp.

Big Rock Partners Acquisition Corp is a blank check company.

On 12/14/2020 the company announced a pending merger wth NueroRX, Inc., a a clinical stage, small molecule pharmaceutical company. NeuroRx develops novel therapeutics for the treatment of COVID-19 (RLF-100 or “ZYESAMI(aviptadil)”) and Bipolar Depression (NRX-100, 101).   

$33.27  +2.34 (7.57%)
As of 05/07/2021 15:53:03 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  12/04/2017
Outstanding shares:  2,688,242
Average volume:  17,716
Market cap:   $84,679,623
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   29.96
PS ratio:   0.00
Return on equity:   -15.69%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy